IgA Nephropathy. The Renaissance Era of Glomerular Diseases and the New Age of Kidney Care

Authors

  • George Vasquez-Rios Glomerular and Genetic Diseases Center, Renal Medicine Associates, New Mexico, USA

DOI:

https://doi.org/10.20453/rmh.v35i4.6203

Downloads

Download data is not yet available.

Author Biography

George Vasquez-Rios , Glomerular and Genetic Diseases Center, Renal Medicine Associates, New Mexico, USA

George Vasquez Rios, MD, MSCR, FASN

Director, Glomerular and Genetic Diseases Center

Co-director, Clinical Trial Research Unit

Renal Medicine Associates, New Mexico, USA

george.vasquez@upch.pe

References

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.

Kiryluk K, Sanchez-Rodriguez E, Zhou XJ, et al. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat Genet. 2023 Jul;55(7):1091-1105. doi: 10.1038/s41588-023-01422-x. Epub 2023 Jun 19.

Trimarchi H, Fervenza FC, Coppo R. Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO. J Nephrol. 2024; 37:739–745. https://doi.org/10.1007/s40620-023-01833-3

Barratt J, Lafayette R, Kristensen J, et al. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19.

Perkovic V, Barratt J, Rovin B, et al. Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy. N Engl J Med. 2024 Oct 25. doi: 10.1056/NEJMoa2410316. Epub ahead of print.

Downloads

Published

2024-12-30

How to Cite

1.
Vasquez-Rios G. IgA Nephropathy. The Renaissance Era of Glomerular Diseases and the New Age of Kidney Care. Rev Méd Hered [Internet]. 2024 Dec. 30 [cited 2025 Feb. 3];35(4):191-3. Available from: http://44.198.254.164/index.php/RMH/article/view/6203

Issue

Vol. 35 No. 4 (2024): Octubre-Diciembre

Section

EDITORIAL

License

Copyright (c) 2024 George Vasquez-Rios

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors assign their rights to the RMH so that may disseminate the article through the means at their disposal. The journal will provide forms of affidavit of authorship and authorization for the publication of the article, which shall be submitted with the manuscript. Authors retain the right to share, copy, distribute, perform and publicly communicate their article, or part of it, mentioning the original publication in the journal.